The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study
Abstract
Background This follow-up study compared patients with schizophrenia with co-occurring substance use disorder to patients with schizophrenia and no substance use disorder.Aims To investigate the prognostic significance of the effects of substance use disorders on the course of schizophrenia.Method Patients with schizophrenia and co-occurring substance use disorder (n=107), and patients with schizophrenia only (n=119) were followed over a 15-year period through the use of national hospitalization registers, data for time and cause of death, and data for homelessness or institutionalization.Results The median length of psychiatric hospitalization was 12 days for a patient with dual diagnosis, and 21 days for patients with schizophrenia only. Patients with dual diagnosis displayed a significantly elevated usage of all types of hospital contacts except inpatient treatment for non-psychiatric disorders. In three types of hospital contacts, patients with co-occurring substance use had approximately two to three times as many hospitalizations as did patients with schizophrenia only. Rates for homelessness and institutionalization were similar in both groups. Patients with a dual diagnosis were also significantly more at risk of dying during follow-up than were patients with schizophrenia only.Conclusions The findings suggest that the long-term course of schizophrenia is considerably more severe in patients who have a dual diagnosis compared to patients with schizophrenia only Substance use disorders have a substantial impact on the hospitalization rates of patients with schizophrenia, as well as on life expectancy. Patients with co-morbid substance abuse are more likely to be admitted for treatment during a given year although they have briefer contact with treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A study focusing on patients with schizophrenia and substance abuse, i.e., a dual diagnosis (Schmidt et al. 2011), found that age at death for these patients was particularly low (49 years).”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Schmidt et al. 2011
In the citing paper
“Conflicting results have been recently reported as to whether illicit drug use contributes to excess mortality in psychosis.2,25,26”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [26]
Citations
Cites
Psychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Volkow, N. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp016 · Cited by 272
McGurk, S. R., Mueser, K. T., DeRosa, T., & Wolfe, R. S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn182 · Cited by 271
Horsfall, J. M., Cleary, M. L., Hunt, G. E., & Walter, G. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902724599 · Cited by 236
Kavanagh, D., Waghorn, G., Jenner, L., Chant, D., Carr, V., Evans, M., Herrman, H., Jablensky, A., & McGrath, J. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00130-0 · Cited by 200
Ten-Year Recovery Outcomes for Clients With Co-Occurring Schizophrenia and Substance Use Disorders
Drake, R. E., McHugo, G. J., Xie, H., Fox, M., Packard, J. D., & Helmstetter, B. S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj064 · Cited by 150
A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system
Williams, J. H., FARMER, A. E., Ackenheil, M., Kaufmann, C. A., & McGuffin, P. (1996) · Psychological Medicine · doi:10.1017/s003329170003779x · Cited by 135
Botha, U. A., Koen, L., Joska, J. A., Parker, J. S., Horn, N. R., Hering, L., & Oosthuizen, P. P. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0085-6 · Cited by 129
Assessment and Treatment Selection for “Revolving Door” Inpatients with Schizophrenia
Weiden, P. J., & Glazer, W. M. (1997) · Psychiatric Quarterly · doi:10.1023/a:1025499131905 · Cited by 121
Risk Factors for Violent Crime in Schizophrenia
Fazel, S., Grann, M., Carlström, E. L., Lichtenstein, P., & Långström, N. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04274 · Cited by 108
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–171 of 171
Sutter, M., Walter, M., Dürsteler, K. M., Strasser, J., & Vogel, M. (2016) · Journal of Dual Diagnosis · doi:10.1080/15504263.2016.1269224 · Cited by 7
Becoming an Evidence-Based Practitioner
Lowis, M. M., Harrison, J., & Wiland, S. (2018) · Community Mental Health Journal · doi:10.1007/s10597-018-0261-9 · Cited by 7
Lazáry, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884654 · Cited by 7
Florentin, S., Rosca, P., Bdolah‐Abram, T., & Neumark, Y. D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.621259 · Cited by 6
Trends in Psychiatric Hospitalizations of Patients With Dual Diagnosis in Spain
Sánchez-Lafuente, C. G., Parra, J. G., Suárez, J., Bordallo-Aragón, A., de Fonseca, F. R., & Mayoral, F. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2022.2053770 · Cited by 6
Rabin, R. A., Goodman, M. S., George, T. P., & Barr, M. S. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0031-x · Cited by 6
Carter, M., Fisher, C. M., & Isaac, M. (2013) · SAGE Open · doi:10.1177/2158244013512133 · Cited by 9
Mortazavi, M., Farsani, Z. A., Rossum, I. W.-V., Kahn, R. S., Fleischhacker, W. W., Davidson, M., Weiser, M., Siskind, D. J., Leucht, S., EULAST Study Group, et al. (2025) · CNS Drugs · doi:10.1007/s40263-025-01225-0 · Cited by 5
Alisauskiene, R., Johnsen, E., Gjestad, R., Kroken, R. A., Kjelby, E., Sinkeviciute, I., Fathian, F., Joa, I., Reitan, S. K., Rettenbacher, M. A., et al. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.05.003 · Cited by 5
Stewart, D., Warren, J., Odubanwo, A., & Bowers, L. (2015) · International Journal of Mental Health Nursing · doi:10.1111/inm.12152 · Cited by 5
Opioid abuse and hospitalization rates in patients with schizophrenia
Kivimies, K., Repo‐Tiihonen, E., Kautiainen, H., Maaranen, P., Muhonen, L. H., Heikkinen, M. E., & Tiihonen, J. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1059884 · Cited by 5
Canela, C., Schleifer, R., Jeger, J., Ebner, G., Seifritz, E., & Liebrenz, M. (2015) · Forensische Psychiatrie Psychologie Kriminologie · doi:10.1007/s11757-014-0302-3 · Cited by 5
Substance Use and Sleep Problems in Patients With Psychotic Disorders
Cederlöf, E., Torniainen‐Holm, M., Ahti, J., Lähteenvuo, M., Hietala, J. A., Häkkinen, K., Isometsä, E. T., Kampman, O., Lahdensuo, K., Lönnqvist, J. K., et al. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac073 · Cited by 5
Peers and Co-Occurring Research-Supported Interventions
Harrison, J., Cousins, L. H., Spybrook, J. K., & Curtis, A. B. (2017) · Journal of Evidence-Informed Social Work · doi:10.1080/23761407.2017.1316220 · Cited by 4
Reinforced therapeutic alliance: The way forward in nursing practice
Bifarin, O. O. (2017) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2017.6.2.95 · Cited by 4
Deng, H., Desai, P. V., Mohite, S., Okusaga, O. O., Zhang, X., Nielsen, D. A., & Kosten, T. R. (2019) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2019.80.230 · Cited by 4
Consumo de Drogas, Rede e Apoio Social entre Pacientes Psiquiátricos Ambulatoriais
Corradi-Webster, C. M., Braga, C. M. D. S., & dos Santos, M. A. (2020) · Revista Avaliação Psicológica · doi:10.15689/ap.2020.1902.03 · Cited by 4
ADHD and schizophrenia: Mere prodromal variant or homogeneous subgroup?
Schulze, J. B., Simnacher, F., Müller, T., Kirchebner, J., Quatela, F., Mikutta, C. A., Euler, S., von Känel, R., & Günther, M. P. (2025) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2025.100374 · Cited by 3
Dobbeltdiagnosepatienters møde med det psykiatriske behandlingssystem
Johansen, K. S., Busch, S., Pinderup, P., Mårtensson, S., & Larsen, J. L. (2018) · Tidsskrift for Forskning i Sygdom og Samfund · doi:10.7146/tfss.v15i28.107264 · Cited by 3
Candelari, A. E., Wojcik, K. D., Williams, J. M., Operskalski, J. T., Safavi, R., & Ojeda, A. A. A. (2025) · Psychiatric Annals · doi:10.3928/00485713-20250108-01 · Cited by 3
Cocaine Use in Individuals With Schizophrenia
Mohite, S., Ngana, I., & Okusaga, O. O. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000110 · Cited by 3
Altunsoy, N., Şahiner, Ş. Y., Cingi, M., Okay, T., Kaymak, S. U., Aydemir, Ç., & Göka, E. (2015) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2015.7679 · Cited by 3
Nam, E., & Fukui, S. (2017) · Journal of Dual Diagnosis · doi:10.1080/15504263.2017.1285092 · Cited by 7
Thiagarajan, S. K., Mok, S. Y., Ogawa, S., Parhar, I. S., & Tang, P. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044088 · Cited by 3
Characterization of substance use in homeless patients with mental disorders
Elmquist, L., Henriksen, M. G., Handest, R., & Nordgaard, J. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2349116 · Cited by 3
REDD-PAC Cohort Description: Researching Dual Diagnosis – Prognosis and Characteristics
Mårtensson, S., Johansen, K. S., Krarup, J., & Düring, S. W. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2022.2055250 · Cited by 3
Deng, H., Mohite, S., Suchting, R., Nielsen, D. A., & Okusaga, O. O. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.089 · Cited by 3
Functioning Problems in Persons with Schizophrenia in the Russian Context
Rojas, M. F. M., Barrios, M., Gómez‐Benito, J., Mikheenkova, N., & Mosolov, S. N. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910276 · Cited by 3
Akdağ, E. M., Kahve, A. C., Diker, R. A., Aydin, S., Barlas, Z. A., & Aktürk, T. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1778865 · Cited by 2
Psychosocial Recovery-Oriented Interventions in Schizophrenia
Barlati, S., Regina, V., Deste, G., Galluzzo, A., Turrina, C., Valsecchi, P., & Vita, A. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_6 · Cited by 2
Wozniak, E. E., Hare, D. J., Gregg, L., & Wittkowski, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1424010 · Cited by 2
Complex needs assessment panel and integrated support: Description and initial evaluation
Watt, B. D., Robin, G., Fleming, L., & Graf, E. (2013) · Advances in Mental Health · doi:10.5172/jamh.2013.11.2.152 · Cited by 2
Substance use patterns in persons with psychosis
Stålheim, J., Berggren, U., Lange, L., & Fahlke, C. (2013) · Mental Health and Substance Use · doi:10.1080/17523281.2012.759129 · Cited by 2
Giampieri, E., Alamia, A., Galimberti, G. L., Tinghino, B., Resentini, M., & Clerici, M. (2013) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 2
Relationship of Teacher Training Levels to Teacher Referrals for Twice Exceptional Students
Jones, R. (2011) · ProQuest Demo Repository · Cited by 2
Huxley, A. (2017) · Addiction · doi:10.1002/9781118489710.ch10 · Cited by 2
Moore, J. R., Castro, Y., DiNitto, D. M., Hernández, M., & Velasquez, M. M. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209349 · Cited by 1
Musket, C. W., Rupert, P. E., Kuo, S. S., Roalf, D. R., Prasad, K. M. R., Wood, J. A., Gur, R. C., Almasy, L. A., Gur, R. E., Nimgaonkar, V. L., et al. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.11.014 · Cited by 1
Brown, E. H., Smith, C. L., Gao, C. X., Williams, G., Talarico, C., Francey, S. M., Telford, N. R., Rickwood, D., Bedi, G., & Thompson, A. (2026) · Psychiatric Services · doi:10.1176/appi.ps.20250309 · Cited by 1
Clinical implications of alcohol-use disorders in schizophrenia
Smith, M. J., & Csernansky, J. G. (2012) · Neuropsychiatry · doi:10.2217/npy.12.21 · Cited by 1
Προδρόμου, Μ., & Koukia, E. (2016) · Dual Diagnosis Open Access · doi:10.21767/2472-5048.100003 · Cited by 1
Gramaglia, C. M., Lombardi, A., Rossi, A., Feggi, A., Bert, F., Siliquini, R., & Zeppegno, P. (2016) · InTech eBooks · doi:10.5772/63102 · Cited by 1
Subramaniam, S., Yee, A. H. A., Nordin, A. S. A., & Khalib, A. Q. (2020) · Journal of Dual Diagnosis · doi:10.1080/15504263.2020.1854410 · Cited by 1
Paruk, S., Ntlantsana, V., Chhagan, U., Tomita, A. M., Karim, E., Thela, L. T., Burns, J. K., & Chiliza, B. (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13464 · Cited by 1
Storman, D., Jemioło, P., Sawiec, Z., Świerz, M. J., Antonowicz, E., Bała, M. M., & Prokop‐Dorner, A. (2024) · Journal of Medical Internet Research · doi:10.2196/51506 · Cited by 2
Linking Substance Use and Schizophrenia
Mutlu, E., Özden, H. C., & Ertuğrul, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-32046-0_179-1 · Cited by 1
Helseth, V. (2013) · Duo Research Archive (University of Oslo) · Cited by 1
Sevale, S. (2015) · University of Nairobi Research Archive (University of Nairobi) · Cited by 1
Lappin, J. (2019) · Addiction · doi:10.1111/add.14791 · Cited by 1
Stålheim, J. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Personality in patients with dual diagnosis: The influence of severe mental illness
Arrico, M., & Julia, E. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
A 1H-MRS and Neurocognitive Analysis of Psychotic Symptoms in Stimulant Dependence
Lakusta, B. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3q04w
Blanchette-Martin, N., Ferland, F., Genois, R., Plourde, C., Dallaire, F., & Labbé, A. (2019) · Canadian Journal of Community Mental Health · doi:10.7870/cjcmh-2019-017
Jahan, S. (2020) · Queensland University of Technology · doi:10.5204/thesis.eprints.180910
Villani, M. R., Pascucci, M., Barone, G., Giordano, M., & Giorgi, A. D. (2021) · MISSION · doi:10.3280/mis55-2020oa10735
Co-occurring Substance Use Disorders and Mental Illness
Avery, J., & Hankins, D. (2021) · Psychiatry update · doi:10.1007/978-3-030-86430-9_12
(2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328352dd8d
Quality of life among dually diagnosed and non-substance-using male schizophrenia outpatients
Aras, H. İ., Yazar, M. S., & Altınbaş, K. (2013) · South African Journal of Psychiatry · doi:10.7196/sajp.416
Soraya, S., خانیها, ح. ا., & Aminpour, A. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220929113437
(2016) · Wiley eBooks · doi:10.1002/9781394259472.refs
Substance Use Disorder and Delusional Symptoms in Patients with Psychosis
Penzenstadler, L. E., Chatton, A., Lecomte, T., Huguelet, P., Lecardeur, L., Bartolomei, J., Brazo, P., Murys, E., Poupart, F., ZULLINO, D. F., et al. (2023) · Swiss Archives of Neurology Psychiatry and Psychotherapy · doi:10.4414/sanp.2023.1264583089
Contingency Management for Dually Diagnosed Inpatients with Psychosis
Docx, L., Destoop, M., & Dom, G. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21050578
The Influence of Family Experience and Environment on Alcohol Use in Patients with Mental Disorders
Kutcher, E. O., Петрова, Н. Н., Pehkonen, S. E. D., Azarova, L. A., Борисович, Д. В., & Varaksa, M. V. (2024) · Psikhiatriya · doi:10.30629/2618-6667-2024-22-3-34-46
Sitnikova, E. O., Sultanova, A. N., Ивановна, З. А., Bukin, A. V., & Сергеевна, Ш. Е. (2025) · Психология и Психотехника · doi:10.7256/2454-0722.2025.3.75589
Linking Substance Use and Schizophrenia
Mutlu, E., Özden, H. C., & Ertuğrul, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_179
Piché, F., Morell, R., Ward, P., Rosenbaum, S., & Romain, A. J. (2026) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2025-0176
Dupuy, M. (2018) · theses.fr (ABES) · doi:10.70675/1f2b3933z599fz43fczb73dz43b9b1f347b7
Reward Circuit Adaptations After Chronic Antipsychotic Treatment Confer Addiction VulnerabilityPreprint
Kruyer, A., Angelis, A., Waselenko, C., Tan, A., Xiong, S., & Amato, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.24.720671
Underdiagnosis of Disorders Due to Substance Use in an Academic Psychiatric Hospital
Eslami, M., Eyvaznejad, B., Rassa, S., Ansari, M., Gholami, J., Rahimi‐Movaghar, A., & Shadloo, B. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2704623
Streymá, D. H. B., Hjorthøj, C. R., Krantz, M. F., Gregersen, M., Nordentoft, M., & Thorup, A. A. E. (2026) · JAACAP Open · doi:10.1016/j.jaacop.2026.09.004
Bonenfant, K. (2013) · Papyrus : Institutional Repository (Université de Montréal)
Metadata
- Authors
- Schmidt, L. M., Hesse, M., & Lykke, J.
- Affiliations
- Sankt Hans Hospital (DK)
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 130
- Issue
- 1-3
- Pages
- 228-233
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2022066531
- Cited by
- 171
- References
- 16
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 10 · 2023: 8 · 2022: 12 · 2021: 10 · 2020: 13 · 2019: 13 · 2018: 15 · 2017: 15 · 2016: 12 · 2015: 11 · 2014: 10 · 2013: 17 · 2012: 10
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Sociology and Political Science › Homelessness and Social Issues
- Keywords
- schizophrenia, substance use disorders
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Cross-Sectional Studies, Denmark, Female, Ill-Housed Persons, Humans, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Prognosis, Psychiatric Department, Hospital, Risk Factors, Schizophrenia, Time Factors, Diagnosis, Dual (Psychiatry), Substance-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review